A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder

Phase: PHASE2 | Sponsor: Stanford University | Compound: Psilocybin

Status

planned

Institution

Stanford University

Start date

2026-07-01

End date

2027-08-01

Registry ID

NCT07479550

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.